Early initiation of sodium‐glucose linked transporter inhibitors (SGLT‐2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients

There is a paucity of data on the use of SGLT2 inhibitors on outcomes in kidney transplant recipients. There may be concern in initiating these agents, especially within the first year post‐transplant when renal function is more labile and immunosuppression more intense, due to a presumed high risk...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Endocrinol Diabetes Metab
Asıl Yazarlar: Song, Chelsey Chenxi, Brown, Andrew, Winstead, Ryan, Yakubu, Idris, Demehin, Moses, Kumar, Dhiren, Gupta, Gaurav
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029504/
https://ncbi.nlm.nih.gov/pubmed/33855198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.185
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller